Literature DB >> 1586022

Electrocardiographic and echocardiographic features of trypanosomiasis in dogs inoculated with North American Trypanosoma cruzi isolates.

S C Barr1, R A Holmes, T R Klei.   

Abstract

Purebred Beagles were inoculated with Trypanosoma cruzi isolates from a North American opossum or armadillo (Tc-W), and dog (Tc-D). Although Tc-D established infection in dogs, the dogs did not develop cardiac abnormalities. Dogs inoculated with Tc-W developed acute myocarditis associated with increases in P-R interval, atrioventricular block, depression of R wave amplitude and shifts in mean electrical axis. Echocardiograms were normal during this stage. Three Tc-W-inoculated dogs died during the acute stage. Following the acute stage, 5 of 8 Tc-W-inoculated dogs entered an indeterminate stage in which ECG changes were minor and echocardiograms were normal. Progression to the chronic stage in 5 of the 8 Tc-W-inoculated dogs was indicated by development of ventricular-based arrhythmias, mainly ventricular premature contractions, between postinoculation days 60 and 170. In some dogs, ventricular premature contractions were multifocal. Electrocardiographic abnormalities progressively degenerated to various forms of ventricular tachycardia. Worsening ECG coincided with loss of left ventricular function as measured by echocardiography. Mean percent ejection fraction and percentage of fractional shortening decreased to 63% and 52% of control values, respectively. The left ventricular free wall (LVFW) thickness decreased and % septal: % LVFW thickening ratio increased, indicating a relative preservation of septal wall motion and LVFW hypokinesis.

Entities:  

Mesh:

Year:  1992        PMID: 1586022

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi.

Authors:  S C Barr; K L Warner; B G Kornreic; J Piscitelli; A Wolfe; L Benet; J H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Restoration of the transient outward potassium current by noradrenaline in chagasic canine epicardium.

Authors:  W Han; S C Barr; L M Pacioretty; R F Gilmour
Journal:  J Physiol       Date:  1997-04-01       Impact factor: 5.182

3.  Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model.

Authors:  Olivia Rodríguez-Morales; M Magdalena Pérez-Leyva; Martha A Ballinas-Verdugo; Silvia C Carrillo-Sánchez; J Luis Rosales-Encina; Ricardo Alejandre-Aguilar; Pedro A Reyes; Minerva Arce-Fonseca
Journal:  Vet Res       Date:  2012-11-13       Impact factor: 3.683

4.  Diagnostic Features of Acute Chagas Myocarditis with Sudden Death in a Family of Boxer Dogs.

Authors:  J P Vitt; A B Saunders; M T O'Brien; J Mansell; D K Ajithdoss; S A Hamer
Journal:  J Vet Intern Med       Date:  2016-05-10       Impact factor: 3.333

5.  Risk factors and select cardiac characteristics in dogs naturally infected with Trypanosoma cruzi presenting to a teaching hospital in Texas.

Authors:  Alyssa C Meyers; Sarah A Hamer; Derek Matthews; Sonya G Gordon; Ashley B Saunders
Journal:  J Vet Intern Med       Date:  2019-05-22       Impact factor: 3.333

6.  Clinical presentation, cardiovascular findings, etiology, and outcome of myocarditis in dogs: 64 cases with presumptive antemortem diagnosis (26 confirmed postmortem) and 137 cases with postmortem diagnosis only (2004-2017).

Authors:  S Lakhdhir; A Viall; E Alloway; B Keene; K Baumgartner; J Ward
Journal:  J Vet Cardiol       Date:  2020-05-29       Impact factor: 1.701

7.  Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model.

Authors:  Olivia Rodríguez-Morales; Silvia C Carrillo-Sánchez; Humberto García-Mendoza; Alberto Aranda-Fraustro; Martha A Ballinas-Verdugo; Ricardo Alejandre-Aguilar; José Luis Rosales-Encina; Maite Vallejo; Minerva Arce-Fonseca
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.